United States · FDA National Drug Code directory
Cetirizine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51660-939_2a87ee90-da59-4e35-9cda-27759ba080d4
- Product NDC
- 51660-939
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- Ohm Laboratories Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071227
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (51660-939-01) · 51660-939-01
- 120 TABLET in 1 BOTTLE (51660-939-13) · 51660-939-13
- 30 TABLET in 1 BOTTLE (51660-939-30) · 51660-939-30
- 300 TABLET in 1 BOTTLE (51660-939-53) · 51660-939-53
- 14 TABLET in 1 BLISTER PACK (51660-939-54) · 51660-939-54
- 90 TABLET in 1 BOTTLE (51660-939-90) · 51660-939-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →